While ethicists, physicians and the news media still gravely debate whether physicians’ loyalties can really be bought for a disposable pen or a free lunch, the $310 billion pharmaceutical industry quietly buys something far more influential:
the contents of medical journals and, all too often, the trajectory
of medical research itself.